Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Glutamine 250 mg/mL in SyrSpend SF pH4 Oral Suspension

Author(s):  Allen Loyd V Jr

Issue:  Jan/Feb 2020 - Volume 24, Number 1
View All Articles in Issue

Page(s):  55

Glutamine 250 mg/mL in SyrSpend SF pH4 Oral Suspension Page 1

Download in electronic PDF format for $75

Abstract:  A formulation for preparing Glutamine 250 mg/mL in SyrSpend SF pH4 Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen, Jr., PhD, RPh, formulation, glutamine, short bowel syndrome, nutritional support, dietary supplementation, recombinant human growth hormone, rHGH

Related Categories: FORMULATIONS, GASTROENTEROLOGY, NUTRITION AND NUTRICEUTICALS

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Glutamine 250 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Jan/Feb 2020
Pg. 55

Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh
Allen Loyd V Jr
Nov/Dec 2003
Pg. 449-450

Compounding in the Pharmacy Curriculum: Beyond the Basics
Hinkle Amanda R
, Newton Gail D
May/Jun 2004
Pg. 181-185

Basics of Compounding for Cough
Allen Loyd V Jr
Nov/Dec 2004
Pg. 462-465

Stability of Alprazolam, Atropine Sulfate, Glutamine, Levofloxacin, Metoprolol Tartrate, Nitrofurantoin, Ondansetron Hydrochloride, Oxandrolone, Pregabaline, and Riboflavin in SyrSpend SF pH4 Oral Suspensions
de Oliveira Ferreira Anderson
, Polonini Hudson C, Loures da Silva Sharlene, Cerqueira de Melo Victor Augusto, de Andrade Laura, Fernandes Brandão Marcos Antônio
May/Jun 2017
Pg. 255-263

Compounding with Biotechnology Products, Part 2: Product-specific Considerations
Allen Loyd V Jr
Nov/Dec 2022
Pg. 446-466

Dapsone 2 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Nov/Dec 2017
Pg. 491

Atropine Sulfate 0.1 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Sep/Oct 2021
Pg. 412

Metoprolol Tartrate 10 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Nov/Dec 2021
Pg. 503

Alprazolam 1 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Mar/Apr 2022
Pg. 140

Riboflavin 10 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Nov/Dec 2019
Pg. 489

Clonazepam 0.2 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Nov/Dec 2018
Pg. 492

Diltiazem Hydrochloride 12 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Nov/Dec 2018
Pg. 493

Enalapril Maleate 1 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Nov/Dec 2018
Pg. 494

Cholecalciferol 50,000 IU/mL in SyrSpend SF pH4
Allen Loyd V Jr
Mar/Apr 2020
Pg. 131

Ketoconazole 20-mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
May/Jun 2017
Pg. 233

Nitrofurantoin 2 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Mar/Apr 2020
Pg. 134

Levofloxacin 50 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Sep/Oct 2020
Pg. 407

Pyridoxine Hydrochloride 50 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Mar/Apr 2022
Pg. 149

Simvastatin 1 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
May/Jun 2018
Pg. 238

Return to Top